Wordt geladen...
Treatment of walking impairment in multiple sclerosis with dalfampridine
Potassium channel blockade has long been considered a potential therapeutic strategy for treatment of multiple sclerosis (MS) based on the pathophysiology of demyelinated axons. Dalfampridine, which is also known as fampridine or 4-aminopyridine (4-AP), is the potassium channel blocker that has been...
Bewaard in:
| Hoofdauteur: | |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
SAGE Publishing
2011-03-01
|
| Reeks: | Therapeutic Advances in Neurological Disorders |
| Online toegang: | https://doi.org/10.1177/1756285611403960 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|